Navigation Links
Emotient Gains Exclusive Rights to New, Expansive Patent Issued for Automated Facial Action Coding System
Date:9/3/2014

SAN DIEGO, Sept. 3, 2014 /PRNewswire/ -- Emotient, the leading provider of facial expression measurement data and analysis, today announced exclusive rights to a newly issued patent (US 8,798,374 B2) entitled, "Automated Facial Action Coding System." This expansive patent protects Emotient's core technology, from face detection to measurement of primary emotions, to detection of facial muscle movements.

"We believe the automated facial action coding patent is very expansive and protects much of our core system," said Ken Denman, President and CEO, Emotient. "We remain committed to growing our intellectual property portfolio. Over the last 18 months, we have filed 16 patent applications to protect additional aspects of our core technology, as well as innovative vertical applications for the retail, health-care, education, and entertainment industries."

The automated facial action coding patent inventors include Emotient Co-Founders Dr. Marian Bartlett, Dr. Gwen Littlefort, Dr. Javier Movellan, Dr. Ian Fasel and their colleague Mark Frank from University of New York. The patent was issued to the Regents of the University of California and The Research Foundation of State University of New York on August 5, 2014. Emotient holds exclusive rights to this and other work that the team developed while at UC San Diego, prior to leaving and co-founding Emotient in 2012. The patent covers the system and method to detect faces and facial features, machine learning techniques for feature selection that are trained on spontaneous expressions; deep neural network applications to machine learning-based classifiers trained on spontaneous expressions and determination of the presence of one or more elementary facial muscle movements or Action Units (AUs).

Emotient is focused on delivering its video-based expression measurement and sentiment analysis software to Global 2000 customers in the market research, retail, education and healthcare verticals. Emotient's software enables businesses to deliver better products, enhance the user experience, and improve patient care. Emotient provides access to critical emotion insights, processing anonymous facial expressions of individuals and groups; the software does not store video or images.  Emotient detects and measures seven facial expressions of primary emotion (joy, surprise, sadness, anger, fear, disgust and contempt); overall sentiments (positive, negative, and neutral), advanced emotions (frustration and confusion) and 19 Action Units (AUs). The Emotient system sets the industry standard for accuracy, with the precise ability to detect single-frame microexpressions of emotions. 

About Emotient – Automated Facial Expression Analysis
(www.emotient.com)
Emotient, Inc., is the leading authority in facial expression analysis. Emotient's software translates facial expressions into actionable information, thereby enabling companies to develop emotion-aware technologies and to create new levels of customer engagement, research, and analysis. For more information on Emotient, please visit www.emotient.com.


'/>"/>
SOURCE Emotient
Copyright©2014 PR Newswire.
All rights reserved

Related biology news :

1. Emotient and iMotions Partner to Offer Unique Integrated Facial Expression Recognition, Bio Sensor and Eye Tracking Solution for Usability, Gaming, Market and Academic/ Scientific Research
2. Green tea polyphenols protect spinal cord neurons against oxidative stress
3. New vaccine shows promise as stronger weapon against both tuberculosis and leprosy
4. Texas Biomed gains $2.7 million NIH grant to research genetic basis of diseases
5. Pinpointing genes that protect against frailty
6. A website to help safeguard the United States borders against alien scale insect pests
7. Atorvastatin protects against cerebral ischemia/reperfusion injury
8. Dissolvable fabric loaded with medicine might offer faster protection against HIV
9. Healthy lifestyle may buffer against stress-related cell aging, study says
10. New drug target can break down cancers barrier against treatment
11. SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2017)... , May 16, 2017  Veratad Technologies, LLC ( ... online age and identity verification solutions, announced today they ... Conference 2017, May 15 thru May 17, 2017, in ... and International Trade Center. Identity impacts ... and in today,s quickly evolving digital world, defining identity ...
(Date:4/24/2017)... Janice Kephart , former 9/11 ... Partners, LLP (IdSP) , today issues the following ... March 6, 2017 Executive Order: Protecting the ... be instilled with greater confidence, enabling the reactivation ... applications are suspended by until at least July ...
(Date:4/17/2017)... , April 17, 2017 NXT-ID, Inc. (NASDAQ: ... announces the filing of its 2016 Annual Report on Form 10-K ... Commission. ... 10-K is available in the Investor Relations section of the Company,s ... the SEC,s website at http://www.sec.gov . 2016 Year ...
Breaking Biology News(10 mins):
(Date:5/23/2017)... ... May 23, 2017 , ... Energetiq ... has announced a facility expansion to accommodate its rapid growth. , The renovations ... workspace and renovation of the existing areas. The expansion includes, a state-of-the-art engineering ...
(Date:5/22/2017)... ... ... Stratevi, a boutique firm that partners with healthcare companies to creatively develop ... in downtown Boston at 745 Atlantic Ave. , “We are seeing that even ... the value they provide, not just to patients, but also payers. Having a presence ...
(Date:5/19/2017)... Shirley, New York (PRWEB) , ... May 19, 2017 , ... ... therapy techniques in treating gait disorders, Biodex Medical Systems, Inc. announces the release of ... time music therapy has been joined with a biomedical system to aid in rehabilitating ...
(Date:5/18/2017)... ... 2017 , ... NDA Partners Chairman Carl Peck, MD , announced today ... and President of Pharmaceutical Development Business Unit of Cardinal Health, has joined the firm ... he was former Chief Operating Officer at Anaborex, Senior VP and General Manager of ...
Breaking Biology Technology: